Oxford Asset Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
2019
Q4
$15K Buy
2019
Q1
Sell
2018
Q4
$141K Buy
2018
Q3
Sell
2018
Q2
$599K Buy
2018
Q1
$166K Buy